Septerna Management
Management criteria checks 2/4
Septerna's CEO is Jeff Finer, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is $2.14M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 1.8% of the company’s shares, worth $16.99M. The average tenure of the management team and the board of directors is 2.1 years and 1.9 years respectively.
Key information
Jeff Finer
Chief executive officer
US$2.1m
Total compensation
| CEO salary percentage | 23.5% |
| CEO tenure | 4.9yrs |
| CEO ownership | 1.8% |
| Management average tenure | 2.1yrs |
| Board average tenure | 1.9yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$20m |
| Jun 30 2024 | n/a | n/a | -US$10m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$2m | US$501k | US$567k |
Compensation vs Market: Jeff's total compensation ($USD2.14M) is below average for companies of similar size in the US market ($USD3.21M).
Compensation vs Earnings: Insufficient data to compare Jeff's compensation with company performance.
CEO
Jeff Finer (58 yo)
4.9yrs
Tenure
US$2,136,260
Compensation
Dr. Jeffrey T. Finer, also known as Jeff, M.D. & Ph D., is Co-Founder & Director of Septerna, Inc. and serves as its Chief Executive Officer from September 2022 and is its President since December 2019. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.9yrs | US$2.14m | 1.8% $ 17.0m | |
| Chief Operating Officer | 2.4yrs | US$883.70k | 0.41% $ 3.9m | |
| Chief People Officer | 1.8yrs | US$771.85k | 0% $ 0 | |
| Senior Vice President of Drug Discovery | 3.1yrs | US$646.74k | 0.22% $ 2.1m | |
| Senior Vice President of Biological Sciences | 3.3yrs | US$578.53k | 0.25% $ 2.4m | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | no data | no data | no data | |
| Interim CFO and VP of Finance & Business Operations | less than a year | no data | 0.14% $ 1.3m | |
| Vice President of Technology | no data | no data | no data | |
| Senior Director of Corporate Development & Portfolio Strategy | 1.8yrs | no data | no data | |
| Senior Vice President of Development Sciences | 1.3yrs | no data | no data |
2.1yrs
Average Tenure
56yo
Average Age
Experienced Management: SEPN's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3yrs | US$2.14m | 1.8% $ 17.0m | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data | |
| Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Chairman of the Board | 4.9yrs | no data | 1.8% $ 17.0m | |
| Independent Director | less than a year | US$100.42k | 0% $ 0 | |
| Director | 1.9yrs | no data | 0.041% $ 391.9k | |
| Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data | |
| Independent Director | 3yrs | no data | no data | |
| Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data | |
| Member of Cross-Functional Scientific & Drug Discovery Advisory Board | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
58yo
Average Age
Experienced Board: SEPN's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.